ReviewAnticipating issues related to increasing preimplantation genetic diagnosis use: a research agenda
Section snippets
Robert Klitzman, MD, is as Associate Professor of Clinical Psychiatry in the College of Physicians and Surgeons and the Mailman School of Public Health at Columbia University. He is the Director of the Ethics and Policy Core of the HIV Center, and a member of the Division of Psychiatry, Law and Ethics, and co-founded and for 5 years co-directed the Center for Bioethics there. He has written numerous articles, and books (including most recently, When Doctors Become Patients), exploring ethical
References (78)
- et al.
Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem
Genetics in Medicine
(2005) - et al.
A ‘neglected part of the curriculum’ or ‘of limited use’? Views on genetic training by nongenetics medical trainees and implications for delivery
Genetics in Medicine
(2006) - et al.
Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey
Genetics in Medicine
(2002) - et al.
Multicentre trial of preimplantation genetic screening reported in the New England Journal of Medicine: an in-depth look at the findings
Reproductive BioMedicine Online
(2007) - et al.
Rare congenital disorders, imprinted genes, and assisted reproductive technology
Lancet
(2003) - et al.
Screening practices and beliefs of assisted reproductive technology programs
Fertility and Sterility
(2005) - et al.
Biopsy of human preimplantation embryos and sexing by DNA amplification
Lancet
(1989) - et al.
To pay or not to pay
Fertility and Sterility
(2003) - et al.
Preimplantation sex selection demand and preferences in an infertility population
Fertility and Sterility
(2005) - et al.
Medical and social perspectives of PGD for single gene disorders and human leukocyte antigen typing
Reproductive BioMedicine Online
(2007)
Opinions about new reproductive genetic technologies: hopes and fears for our genetic future
Fertility and Sterility
PGD patients' and providers' attitudes to the use and regulation of preimplantation genetic diagnosis
Reproductive BioMedicine Online
A survey of the practices and opinions of the domestic members of the American Society for Reproductive Medicine
Fertility and Sterility
The roles of family members, health care workers and others in decision-making processes about genetic testing among individuals at risk for Huntington's disease
Genetics in Medicine
Controversy over deliberate conception of deaf child
Lancet
Psychosocial adjustment and the quality of the mother-child relationship at four months postpartum after conception by in-vitro fertilization
Fertility and Sterility
Does insurance coverage decrease the risk for multiple births associated with assisted reproductive technology?
Fertility and Sterility
Perimplantation genetic diagnosis
Lancet
Birth after the reimplantation of a human embryo
Lancet
Barriers to the provisions of genetic services by primary care physicians: A systematic review of the literature
Genetics in Medicine
State Infertility Insurance Laws
Genetic testing of embryos: practices and perspectives of U.S. IVF clinics
Fertility and Sterility
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder
Molecular Psychiatry
Body composition in children and adolescents born after in-vitro fertilization or spontaneous conception
Journal of Clinical Endocrinology and Metabolism
National Vital Statistics Report
Assisted Reproductive Technology (ART) Report: 2005 Preliminary Clinic Data by State and National Summary
Assisted Reproductive Technology (ART) Report: 2005 Preliminary Accessible National Summary
Assisted Reproductive Technology (ART) Report
Attitude of potential users in Sicily towards preimplantation genetic diagnosis of beta-thalassemia and aneuoploidies
Human Reproduction
Societal involvement in prenatal diagnosis
Journal of the American Medical Association
Ethical implications of a new application of preimplantation diagnosis
Journal of the American Medical Association
Genome-wide association study identifies novel breast cancer susceptibility loci
Nature
Europe struggles to meet the legal, ethical and regulatory challenges posed by patients travelling abroad for PGD. 23rd Annual Meeting
ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005
Human Reproduction
ESHRE Preimplantation Genetic Diagnosis (PGD) Consortium: data collection II (May 2000)
Human Reproduction
ESHRE Preimplantation Genetic Diagnosis (PGD) Consortium: preliminary assessment of data from January 1997 to September 1998
Human Reproduction
Preimplantation testing to produce an HLA-matched donor infant
Journal of the American Medical Association
Fluorescent PCR: a new technique for PGD of sex and single-gene defects
Journal of Assisted Reproduction and Genetics
Conception for donation
Journal of the American Medical Association
Cited by (20)
What to expect from assisted reproductive technologies? Experts' forecasts for the next two decades
2019, Technological Forecasting and Social ChangeCitation Excerpt :It also opens the way for fertility preservation both for medical and non-medical reasons (Bhatia and Campo-Engelstein, 2018; Dondorp et al., 2012). Preimplantation Genetic Diagnosis (PGD), introduced in 1990, is typically practiced to prevent the birth of infants with severe disorders, usually monogenic, of early onset, and of a high level of penetrance (Batzer and Ravitsky, 2009; Klitzman, 2008). However, it is also occasionally used for severe diseases of late onset and partial penetrance, such as neurodegenerative disorders and genetic malignancy risks (Altarescu et al., 2015).
The decision-making process of genetically at-risk couples considering preimplantation genetic diagnosis: Initial findings from a grounded theory study
2012, Social Science and MedicineCitation Excerpt :Lingering questions remain surrounding how social and personal factors such as cost, greater social acceptance, past reproductive history, and religious views impact the decision and ultimately how couples construct preferences and values to determine whether to use PGD. Research that further examines these underlying processes regarding how couples move into each of the decision types, in a larger and more theoretically diverse sample, is needed and would benefit couples, clinicians, and policy makers (Green & Guyer, 2011; Hershberger & Pierce, 2010; Klitzman et al., 2008). Clinicians can apply the findings through increased understanding and recognition of the decision-making process that couples undergo surrounding PGD use by tailoring counseling, education, and support during the four phases of the model.
High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: A systematic review and meta-analysis
2012, Genetics in MedicineCitation Excerpt :Because PGD is procedurally performed in conjunction with standard IVF procedures, it is difficult to know whether these adverse outcomes are the result of PGD or the IVF process, although recent research suggests that there are no significant differences found between the outcomes of PGD born children and IVF born children.14,15,16 Ethical concerns of IVF and PGD include the potential discarding of embryos that are positive for the hereditary condition, the long-term storage of embryos, and embryo donation.17,18,19 A considerable amount of research has focused on the ethical implications of PGD for gender selection and other physical attributes, a relatively new use of PGD.
Unraveling Preimplantation Genetic Diagnosis for High-Risk Couples: Implications for Nurses at the Front Line of Care
2011, Nursing for Women's HealthCitation Excerpt :Another important implication is the need for nurses to encourage and support research in the field. Especially significant is research that is aimed at understanding and answering challenging decision-making questions surrounding PGD use (Klitzman, Appelbaum, Chung, & Sauer, 2008). Nurses can assist in this effort by informing couples about ongoing research in this area and advocating for additional governmental and private research support.
Conceptualizing couples' decision making in PGD: Emerging cognitive, emotional, and moral dimensions
2010, Patient Education and CounselingOpinions concerning pre-implantation genetic diagnosis and sex selection among gynecologist-obstetricians in Brazil
2010, European Journal of Obstetrics and Gynecology and Reproductive BiologyCitation Excerpt :In our study agreement with PGD was higher (71.6%) than agreement with SS (46.2%). In spite of ethical concerns for non-medical PGD indications, it has become widely practiced throughout the world, and it can substantially decrease the eventual risks of passing a genetic condition to the offspring [28,29]. Respondents who had children were more likely to approve of PGD, probably due to the experience as parents, they are more likely to be concerned about the health of an offspring.
Robert Klitzman, MD, is as Associate Professor of Clinical Psychiatry in the College of Physicians and Surgeons and the Mailman School of Public Health at Columbia University. He is the Director of the Ethics and Policy Core of the HIV Center, and a member of the Division of Psychiatry, Law and Ethics, and co-founded and for 5 years co-directed the Center for Bioethics there. He has written numerous articles, and books (including most recently, When Doctors Become Patients), exploring ethical and policy issues concerning genetics, stigma and discrimination of genetic disease and HIV, professional socialization and training, and other areas.
Declaration: The authors report no financial or commercial conflicts of interest.